secwatch / observer
8-K filed March 2, 2023, 6:59 PM ET ticker COCH CIK 0001840877
other material confidence high sentiment negative materiality 0.80

Anzu SPAC extends deadline to Sept 30, 2023; ~$387.5M redeemed, trust drops to $45.2M

Envoy Medical, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Envoy Medical, Inc. shareholders rejected Adjournment Proposal: adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies at the 2023-02-28 meeting.

Outcome
failed
Meeting
2023-02-28
Exact text from the filing
Proposal No. 2 - The Adjournment Proposal – The stockholders approved a proposal to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Stockholder Meeting, there are insufficient shares Common Stock represented (either in person or by proxy) to constitute a quorum necessary to conduct business at the Special Meeting or at the time of the Special Meeting to approve the Extension Amendment Proposal or if the Maximum Redemption Condition (as defined in the Proxy Statement) is not met and is not waived by the Board in its sole discretion (the “ Adjournment Proposal ”). Passage of the Adjournment Proposal required a majority of the Company’s outstanding shares of Common Stock. The voting results were as follows: For Against Abstain 38,984,445 3,985,790 0 Although the Adjournment Proposal received sufficient votes to be approved, it was not presented for adoption and no mo
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Envoy Medical, Inc. shareholders approved Extension Amendment Proposal: amend the amended and restated certificate of incorporation to extend the date by which the Company has to consummate an initial business combination from March 4, 2023 to September 30, 2023 or such earlier date as determined by the Board at the 2023-02-28 meeting.

Proposal
charter amendment
Outcome
passed
Meeting
2023-02-28
Exact text from the filing
Proposal No. 1 - The Extension Amendment Proposal – The stockholders approved a proposal to amend the Company’s amended and restated certificate of incorporation to extend the date by which the Company has to consummate an initial business combination from March 4, 2023 to September 30, 2023 or such earlier date as determined by the Board (the “ Extension Amendment Proposal ”). Passage of the Extension Amendment Proposal required approval by the affirmative vote of at least 65% of the Company’s issued and outstanding shares of Common Stock. The voting results were as follows: For Against Abstain 36,753,901 6,216,334 0
View on SEC.gov

56 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Envoy Medical, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-23-027594
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.